Exact Mass: 448.1787
Exact Mass Matches: 448.1787
Found 348 metabolites which its exact mass value is equals to given mass value 448.1787
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Lonchocarpenin
A hydroxycoumarin that is 2H,8H-benzo[1,2-b:5,4-b]dipyran-2-one substituted by a hydroxy group at position 4, a methoxy group at position 5, 4-methoxyphenyl group at position 3 and two methyl groups at position 8 respectively.
1,3-Benzenedicarbonitrile, 2-[[4-[[2-(acetyloxy)ethyl]butylamino]-2-methylphenyl]azo]-5-nitro-
Ethyl [3,4,5-trihydroxy-6-[2-[(4-methoxyphenyl)methyl]phenoxy]oxan-2-yl]methyl carbonate
4-((4-(1H-Tetrazol-1-yl)phenoxy)methyl)-2-(1-(5-ethylpyrimidin-2-yl)piperidin-4-yl)thiazole
(4R*,6Z,8R*,10S*,11E)-8-(Acetyloxy)-3-[(acetyloxy)methyl]-2,4,5,8,9,10-hexahydro-10-hydroxy-6,10-dimethyl-2-oxocyclodeca[b]furan-4-yl ester 2-methyl-2-propenoic acid
Manuifolin Q
(3S)-8-(beta-D-glucopyranosyloxy)-3-[(1E,3E,5E)-hepta-1,3,5-trienyl]-3,4-dihydro-6-hydroxy-5-methyl-1H-2-benzopyran-1-one|(3S,11E,13E,15E)-8-(beta-D-glucopyranosyloxy)-3-heptatrienyl-6-hydroxy-5-methylisochroman-1-one
3-carbomethoxynaphtho[1,2-b]-3,3-dimethylpyran-4-O-beta-D-glucopyranoside
Pierreione C
A methoxyisoflavone that is isoflavone substituted by methoxy groups at positions 5 and 3, a prenyloxy group at position 4 and a dimethylpyran ring fused across positions 6 and 7. Isolated from Antheroporum pierrei, it exhibits antineoplastic activity.
Prenylcandidusin B
A member of the class of dibenzofurans that is 1,4,7,8-tetramethoxydibenzo[b,d]furan substituted by a 4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl substituent at position 3. It has been isolated from Aspergillus taichungensis.
5-hydroxy-6-methyl-2-methoxy-[6,6-dimethylpyrano(2,3:7,8)][6,6dimethylpyrano(2,3:4,5)]-(2S)-flavone
(7S,8S,10S)-[tetrahydro-4-hydroxy-2-(3,4,5-trimethoxyphenyl)furan-3-yl]methyl 3,4-dimethoxy benzoate
rel-(2Z)-2-{(1E)-2-[(1R,4R,4aR,7R,8S,8aS)-3,4,4a,5,6,7,8,8a-octahydro-4-hydroxy-7-(methoxycarbonyl)-4a,8-dimethyl-3-oxo-1,4-etheno-1H-2-benzopyran-8-yl]ethenyl}but-2-enedioic acid dimethyl ester|tinocapilactone A
(4bS,7R,8R,8aR,9S,10S)-8-(acetoxy)methyl-7-formyloxy-3,9,10-trihydroxy-4b,8-dimethyl-2-(2-propenyl)-4b,5,6,7,8,8a,9,10-octahydrophenanthren-1,4-dion
2-carbomethoxy-3-prenyl-1,4-naphthohydroquinone-4-O-beta-D-glucopyranoside|2-carbomethoxy-3-prenyl-1,4-naphthohydroquinone-4-O-beta-D-glucoside
2alpha,13-diacetoxy-4alpha-hydroxy-8alpha-methacryloyloxy-bourbonen-12,6alpha-olide|2alpha,13-diacetoxy-4alpha-hydroxy-8alpha-methacryloyloxybourbonen-12,6alpha-olide
1,4-Dihydroxy-2-carbomethoxy-3-prenylnaphthalene-1-O-beta-glucopyranoside
C23H28O9_(1aS,3R,4R,5S,5aS,8aR,10R,10aS)-3-Hydroxy-3,10-dimethyl-6-methylene-2,7-dioxododecahydrooxireno[7,8]cyclodeca[1,2-b]furan-4,5-diyl bis(2-methylacrylate)
(1R,3R,4S,6S,8R,9R,10S,11S)-8-hydroxy-3,8-dimethyl-12-methylidene-10-[(2-methylprop-2-enoyl)oxy]-7,13-dioxo-5,14-dioxatricyclo[9.3.0.0⁴,⁶]tetradecan-9-yl 2-methylprop-2-enoate
(1R,3R,4S,6S,8R,9R,10S,11S)-8-hydroxy-3,8-dimethyl-12-methylidene-10-[(2-methylprop-2-enoyl)oxy]-7,13-dioxo-5,14-dioxatricyclo[9.3.0.0⁴,⁶]tetradecan-9-yl 2-methylprop-2-enoate_major
Ala Cys Gln Gln
Ala Glu Glu Thr
Ala Glu Thr Glu
Ala Met Met Pro
Ala Met Asn Asn
Ala Met Pro Met
Ala Asn Met Asn
Ala Asn Asn Met
Ala Pro Met Met
Ala Gln Cys Gln
Ala Gln Gln Cys
Ala Thr Glu Glu
Cys Ala Gln Gln
Cys Gly Asn Arg
Cys Gly Arg Asn
Cys Met Pro Val
Cys Met Val Pro
Cys Asn Gly Arg
Cys Asn Asn Val
Cys Asn Arg Gly
Cys Asn Val Asn
Cys Pro Met Val
Cys Pro Val Met
Cys Gln Ala Gln
Cys Gln Gln Ala
Cys Arg Gly Asn
Cys Arg Asn Gly
Cys Val Met Pro
Cys Val Asn Asn
Cys Val Pro Met
Asp Asp Ile Ser
Asp Asp Leu Ser
Asp Asp Ser Ile
Asp Asp Ser Leu
Asp Asp Thr Val
Asp Asp Val Thr
Asp Glu Ser Val
Asp Glu Val Ser
Asp Ile Asp Ser
Asp Ile Ser Asp
Asp Leu Asp Ser
Asp Leu Ser Asp
Asp Ser Asp Ile
Asp Ser Asp Leu
Asp Ser Glu Val
Asp Ser Ile Asp
Asp Ser Leu Asp
Asp Ser Val Glu
Asp Thr Asp Val
Asp Thr Val Asp
Asp Val Asp Thr
Asp Val Glu Ser
Asp Val Ser Glu
Asp Val Thr Asp
Glu Ala Glu Thr
Glu Ala Thr Glu
Glu Asp Ser Val
Glu Asp Val Ser
Glu Glu Ala Thr
Glu Glu Thr Ala
Glu Ser Asp Val
Glu Ser Val Asp
Glu Thr Ala Glu
Glu Thr Glu Ala
Glu Val Asp Ser
Glu Val Ser Asp
Gly Cys Asn Arg
Gly Cys Arg Asn
Gly Met Asn Gln
Gly Met Gln Asn
Gly Asn Cys Arg
Gly Asn Met Gln
Gly Asn Gln Met
Gly Asn Arg Cys
Gly Gln Met Asn
Gly Gln Asn Met
Gly Arg Cys Asn
Gly Arg Asn Cys
Ile Asp Asp Ser
Ile Asp Ser Asp
Ile Ser Asp Asp
Leu Asp Asp Ser
Leu Asp Ser Asp
Leu Ser Asp Asp
Met Ala Met Pro
Met Ala Asn Asn
Met Ala Pro Met
Met Cys Pro Val
Met Cys Val Pro
Met Gly Asn Gln
Met Gly Gln Asn
Met Met Ala Pro
Met Met Pro Ala
Met Asn Ala Asn
Met Asn Gly Gln
Met Asn Asn Ala
Met Asn Gln Gly
Met Pro Ala Met
Met Pro Cys Val
Met Pro Met Ala
Met Pro Val Cys
Met Gln Gly Asn
Met Gln Asn Gly
Met Val Cys Pro
Met Val Pro Cys
Asn Ala Met Asn
Asn Ala Asn Met
Asn Cys Gly Arg
Asn Cys Asn Val
Asn Cys Arg Gly
Asn Cys Val Asn
Asn Gly Cys Arg
Asn Gly Met Gln
Asn Gly Gln Met
Asn Gly Arg Cys
Asn Met Ala Asn
Asn Met Gly Gln
Asn Met Asn Ala
Asn Met Gln Gly
Asn Asn Ala Met
Asn Asn Cys Val
Asn Asn Met Ala
Asn Asn Val Cys
Asn Gln Gly Met
Asn Gln Met Gly
Asn Arg Cys Gly
Asn Arg Gly Cys
Asn Val Cys Asn
Asn Val Asn Cys
Pro Ala Met Met
Pro Cys Met Val
Pro Cys Val Met
Pro Met Ala Met
Pro Met Cys Val
Pro Met Met Ala
Pro Met Val Cys
Pro Val Cys Met
Pro Val Met Cys
Gln Ala Cys Gln
Gln Ala Gln Cys
Gln Cys Ala Gln
Gln Cys Gln Ala
Gln Gly Met Asn
Gln Gly Asn Met
Gln Met Gly Asn
Gln Met Asn Gly
Gln Asn Gly Met
Gln Asn Met Gly
Gln Gln Ala Cys
Gln Gln Cys Ala
Arg Cys Gly Asn
Arg Cys Asn Gly
Arg Gly Cys Asn
Arg Gly Asn Cys
Arg Asn Cys Gly
Arg Asn Gly Cys
Ser Asp Asp Ile
Ser Asp Asp Leu
Ser Asp Glu Val
Ser Asp Ile Asp
Ser Asp Leu Asp
Ser Asp Val Glu
Ser Glu Asp Val
Ser Glu Val Asp
Ser Ile Asp Asp
Ser Leu Asp Asp
Ser Val Asp Glu
Ser Val Glu Asp
Thr Ala Glu Glu
Thr Asp Asp Val
Thr Asp Val Asp
Thr Glu Ala Glu
Thr Glu Glu Ala
Thr Val Asp Asp
Val Cys Met Pro
Val Cys Asn Asn
Val Cys Pro Met
Val Asp Asp Thr
Val Asp Glu Ser
Val Asp Ser Glu
Val Asp Thr Asp
Val Glu Asp Ser
Val Glu Ser Asp
Val Met Cys Pro
Val Met Pro Cys
Val Asn Cys Asn
Val Asn Asn Cys
Val Pro Cys Met
Val Pro Met Cys
Val Ser Asp Glu
Val Ser Glu Asp
Val Thr Asp Asp
Karenitecin
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor
Sergliflozin etabonate
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent D007004 - Hypoglycemic Agents > D000077203 - Sodium-Glucose Transporter 2 Inhibitors C471 - Enzyme Inhibitor > C98083 - SGLT2 Inhibitor
4-[(5,5-dimethyl-8-quinolin-3-yl-6H-naphthalene-2-carbonyl)amino]benzoic acid
N-(4-(4-Aminopiperidin-1-yl)-2-methoxyphenyl)-5-chloro-4-(1H-indol-3-yl)pyrimidin-2-amine
N-[2-(3,4-diethoxyphenyl)ethyl]-4-(phenylmethyl)-5-thieno[3,2-b]pyrrolecarboxamide
Technetium Tc-99m disofenin
V - Various > V09 - Diagnostic radiopharmaceuticals > V09D - Hepatic and reticulo endothelial system > V09DA - Technetium (99mtc) compounds D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D019275 - Radiopharmaceuticals C1446 - Radiopharmaceutical Compound > C2124 - Radioconjugate
4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-Benzodioxol-5-ylmethyl)-7-hydroxy-1,3-dioxodecahydropyrrolo[3,4-A]pyrrolizin-4-YL]benzenecarboximidamide
2-(6-Chloro-3-{[2,2-difluoro-2-(2-pyridinyl)ethyl]amino}-2-oxo-1(2H)-pyrazinyl)-N-[(2-fluoro-3-methyl-6-pyridinyl)methyl]acetamide
(2s)-2-[3-(Aminomethyl)phenyl]-3-[(R)-[(1r)-1-{[(Benzyloxy)carbonyl]amino}-2-Methylpropyl](Hydroxy)phosphoryl]propanoic Acid
N-[3-(cyclohexylthio)propyl]-2-[[5-methyl-2-(3-methylphenyl)-4-oxazolyl]methylsulfinyl]acetamide
4-[[9-[(3R)-3-oxolanyl]-8-(2,4,6-trifluoroanilino)-2-purinyl]amino]-1-cyclohexanol
1-(3-Sulfopropyl)-4-[(1e,3e)-3-(1,3,3-Trimethyl-1,3-Dihydro-2h-Indol-2-Ylidene)prop-1-En-1-Yl]quinolinium
D004396 - Coloring Agents > D002232 - Carbocyanines
5-[3-((E)-{[3-(dimethylamino)benzoyl]hydrazono}methyl)-2,5-dimethyl-1H-pyrrol-1-yl]isophthalic acid
1-(4-Fluorophenyl)-4-[[1-(2-phenylethyl)-5-tetrazolyl]-thiophen-2-ylmethyl]piperazine
1-Butyl-2-[2-furanyl(oxo)methyl]imino-10-methyl-5-oxo-3-dipyrido[3,4-c:1,2-f]pyrimidinecarboxylic acid ethyl ester
methyl (3aR,4R,5R,6E,10E,11aR)-5-acetyloxy-4-[(2S,3S)-2,3-dimethyloxirane-2-carbonyl]oxy-10-methyl-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-6-carboxylate
methyl (3aS,4S,5S,6E,10Z,11aR)-5-acetyloxy-4-[(2S,3S)-2,3-dimethyloxirane-2-carbonyl]oxy-10-methyl-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-6-carboxylate
methyl (3aS,4S,5S,6E,10E,11aR)-5-acetyloxy-4-[(2S,3S)-2,3-dimethyloxirane-2-carbonyl]oxy-10-methyl-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-6-carboxylate
CNT2 inhibitor-1
CNT2 inhibitor-1 is a potent concentrative nucleoside transporter 2 Inhibitor (CNT2), with an IC50 of 640 nM for hCNT2.